Citation Impact
Citing Papers
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts
2008
Effects of acrylamide on creatine kinase from rabbit muscle
2001
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Chemosensitivity linked to p73 function
2003 StandoutNobel
Structure of a Voltage-Dependent K+ Channel β Subunit
1999 StandoutNobel
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
CD44: From adhesion molecules to signalling regulators
2003 Standout
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
2011
The Crystal Structure and Mutational Analysis of Human NUDT9
2003
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
A novel nicotinoprotein aldehyde dehydrogenase involved in polyethylene glycol degradation
2005
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
2014
Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73
2003
ERM proteins and merlin: integrators at the cell cortex
2002 Standout
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
2006
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
2008
CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields
2009 Standout
Delivery materials for siRNA therapeutics
2013 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Molecular recognition of aldehydes by aldehyde dehydrogenase and mechanism of nucleophile activation
2004
Chemistry, Biochemistry, and Safety of Acrylamide. A Review
2003 Standout
Lipid-based systemic delivery of siRNA
2009
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Biomedical applications of biodegradable polymers
2011 Standout
Interaction between the Functional Polymorphisms of the Alcohol-Metabolism Genes in Protection against Alcoholism
1999
Aptamers as therapeutics
2010 Standout
Non-viral vectors for gene-based therapy
2014 Standout
NUDT9, a Member of the Nudix Hydrolase Family, Is an Evolutionarily Conserved Mitochondrial ADP-ribose Pyrophosphatase
2003
TRP channels as cellular sensors
2003 StandoutNature
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells
2000
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Specific β1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia
2006
An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure
2013
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
2013 Standout
Protein carbonyl groups as biomarkers of oxidative stress
2003 Standout
Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia
2018
Identification of basolateral membrane targeting signal of human sodium‐dependent dicarboxylate transporter 3
2005
Analysis of O-Acetyl-ADP-ribose as a Target for Nudix ADP-ribose Hydrolases
2002
A Map of Recent Positive Selection in the Human Genome
2006 Standout
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
2006
Liposomes as nanomedical devices
2015 Standout
RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy
2006
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Nonviral delivery of synthetic siRNAs in vivo
2007
Knocking down barriers: advances in siRNA delivery
2009 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
How culture shaped the human genome: bringing genetics and the human sciences together
2010 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain
2000
Cystatin M / E expression in inflammatory and neoplastic skin disorders
2002
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Structure and Activity Analyses of Escherichia coli K-12 NagD Provide Insight into the Evolution of Biochemical Function in the Haloalkanoic Acid Dehalogenase Superfamily,
2006
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Exosomes
2019 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors
2006
Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo–keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase
1998
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Current Trends in The Use of Liposomes for Tumor Targeting
2013
Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy
2006
Selective Inhibitors of Human Lactate Dehydrogenases and Lactate Dehydrogenase from the Malarial Parasite Plasmodium falciparum
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Piezo1 channels restrain regulatory T cells but are dispensable for effector CD4 + T cell responses
2021 Standout
Mammalian Sirtuins: Biological Insights and Disease Relevance
2010 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective
2010 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Lipids and Lipid Derivatives for RNA Delivery
2021
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
2019 StandoutNobel
Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
2008
Systematic Screening and Therapeutic Evaluation of Glyconanoparticles with Differential Cancer Affinities for Targeted Cancer Therapy
2022
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
ERM-Merlin and EBP50 Protein Families in Plasma Membrane Organization and Function
2000
Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
2014
Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents
2005
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Overcoming obstacles to develop effective and safe siRNA therapeutics
2009
Preservation of phosphagen kinase function during transient hypoxia via enzyme abundance or resistance to oxidative inactivation
1996
Creatine and Creatinine Metabolism
2000 Standout
Fluorinated organophosphates for biomedical targets
2008
Works of Saifuddin Sheikh being referenced
Heterotetramers of Human Liver Mitochondrial (Class 2) Aldehyde Dehydrogenase Expressed in Escherichia coli
1996
Chemical modification of octopine dehydrogenase by thiol-specific reagents: evidence for the presence of an essential cysteine at the catalytic site
1993
The Potential Roles of the Conserved Amino Acids in Human Liver Mitochondrial Aldehyde Dehydrogenase
1997
Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo
2004
Synthesis and biological evaluation of gemcitabine–lipid conjugate (NEO6002)
2005
Enhanced therapeutic efficacy of a novel liposome-based formulation of SN-38 against human tumor models in SCID mice
2004
Evidence for proximal cysteine and lysine residues present at the nucleotide domain of rabbit muscle creatine kinase
1993
Orally administered Endoxifen is a new therapeutic agent for breast cancer
2010
Identification and Characterization of the Nudix Hydrolase from the Archaeon, Methanococcus jannaschii, as a Highly Specific ADP-ribose Pyrophosphatase
1998
Involvement of Glutamate 399 and Lysine 192 in the Mechanism of Human Liver Mitochondrial Aldehyde Dehydrogenase
1997
Therapeutic Efficacy of a Novel Nanosomal Docetaxel Lipid Suspension Compared With Taxotere in Locally Advanced or Metastatic Breast Cancer Patients
2013
Allosteric inhibition of human liver aldehyde dehydrogenase by the isoflavone prunetin
1997
Synthesis of cationic cardiolipin analogues
2005
Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation.
2005